Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression

(2011) J Lin et al.   BRITISH JOURNAL OF CANCER

KIT as a Therapeutic Target in Metastatic Melanoma

(2011) Richard D. Carvajal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification

(2011) Jun Guo et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment implications of the emerging molecular classification system for melanoma

(2011) Emanuela Romano et al.   LANCET ONCOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells

(2010) Sabine Riethdorf et al.   Annals of the New York Academy of Sciences

Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics

(2010) Scott E. Woodman et al.   BIOCHEMICAL PHARMACOLOGY

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer

(2010) L M Flores et al.   BRITISH JOURNAL OF CANCER

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

(2010) Sonja J. Heidorn et al.   CELL

Circulating Tumor Cells in Colorectal Cancer: Past, Present, and Future Challenges

(2010) Benjamin P. Negin et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

(2010) Gillian Ellison et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma

(2010) Vincenzo De Giorgi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

(2010) Georgia Hatzivassiliou et al.   NATURE

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating tumour cells: their utility in cancer management and predicting outcomes

(2010) Matthew G. Krebs et al.   Therapeutic Advances in Medical Oncology

Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study

(2009) Daniela Suesskind et al.   ACTA OPHTHALMOLOGICA

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

(2009) Marta Pestrin et al.   BREAST CANCER RESEARCH AND TREATMENT

In vivo, Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser

(2009) E. I. Galanzha et al.   CANCER RESEARCH

mRNA Expression and BRAF Mutation in Circulating Melanoma Cells Isolated from Peripheral Blood with High Molecular Weight Melanoma-Associated Antigen-Specific Monoclonal Antibody Beads

(2009) M. Kitago et al.   CLINICAL CHEMISTRY

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Response to Imatinib Mesylate Depends on the Presence of the V559A-Mutated KIT Oncogene

(2009) Patrick Terheyden et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Polyclonality of BRAF Mutations in Acquired Melanocytic Nevi

(2009) Jingrong Lin et al.   JNCI-Journal of the National Cancer Institute

Dormancy of metastatic melanoma

(2009) Liliana Ossowski et al.   Pigment Cell & Melanoma Research

Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer

(2008) Nikolas H. Stoecklein et al.   CANCER CELL

Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate

(2008) U. B. Hofmann et al.   CLINICAL CANCER RESEARCH

Detection of Mutations inEGFRin Circulating Lung-Cancer Cells

(2008) Shyamala Maheswaran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset

(2008) Fanny Lanternier et al.   PLoS One